- Access to this full-text is provided by American Society for Microbiology.
- Learn more
Download available
Content available from Genome Announcements
This content is subject to copyright. Terms and conditions apply.
Complete Genome Sequences of a Clinical Isolate and an
Environmental Isolate of Vibrio parahaemolyticus
Catharina H. M. Lüdeke,
a,b
Nguyet Kong,
c,d
Bart C. Weimer,
c,d
Markus Fischer,
b
Jessica L. Jones
a
Gulf Coast Seafood Laboratory, Division of Seafood Science and Technology, Food and Drug Administration, Dauphin Island, Alabama, USA
a
; Hamburg School of Food
Science, University of Hamburg, Hamburg, Germany
b
; School of Veterinary Medicine
c
and 100K Pathogen Genome Project,
d
University of California, Davis, California, USA
Vibrio parahaemolyticus is the leading cause of seafood-borne infections in the United States. We report complete genome se-
quences for two V. parahaemolyticus strains isolated in 2007, CDC_K4557 and FDA_R31 of clinical and oyster origin, respec-
tively. These two sequences might assist in the investigation of differential virulence of this organism.
Received 13 February 2015 Accepted 18 February 2015 Published 26 March 2015
Citation Lüdeke CHM, Kong N, Weimer BC, Fischer M, Jones JL. 2015. Complete genome sequences of a clinical isolate and an environmental isolate of Vibrio
parahaemolyticus. Genome Announc 3(2):e00216-15. doi:10.1128/genomeA.00216-15.
Copyright © 2015 Lüdeke et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 Unported license.
Address correspondence to Jessica L. Jones, jessica.jones@fda.hhs.gov.
Vibrio parahaemolyticus is a halophilic Gram-negative bacte-
rium naturally occurring in estuarine environments (1).
Through consumption of raw or undercooked seafood, or contact
with contaminated seawater, V. parahaemolyticus can cause infec-
tions in humans; gastroenteritis is typical, but rarely, wound
and/or sepsis infections occur. V. parahaemolyticus is the leading
cause of seafood-borne gastroenteritis in the United States (2),
and there has been an increase in reported illnesses in the last two
decades (3).
V. parahaemolyticus can carry the thermostable direct hemoly-
sin (tdh) and tdh-related hemolysin (trh) genes, which are gener-
ally associated with pathogenicity and are used in outbreak inves-
tigations and assessing risk (4,5). Clinical isolates more frequently
carry the tdh and/or trh genes than environmental isolates (6).
However, in recent studies, clinical isolates lacking both of these
genes have been identified (7). Tissue culture studies have re-
vealed that the presence of tdh had no effect on cytotoxicity (8,9).
Hence, additional virulence factors likely exist for V. parahaemo-
lyticus.
We sequenced two V. parahaemolyticus isolates, CDC_K4557
and FDA_R31, to better understand the pathogenic potential of
these isolates and eventually improve risk assessment.
CDC_K4557 was isolated from the stool of a patient in Louisiana
in 2007 and submitted to the Centers for Disease Control and
Prevention (CDC). FDA_R31 was isolated by the Food and Drug
Administration (FDA) from an oyster sample harvested in Loui-
siana in 2007. As the clinical isolate is tdh
⫺
trh
⫺
and the oyster
isolate is tdh
⫹
trh
⫹
by PCR, these strains are ideal for identifying
new and/or additional virulence markers.
The genomes were sequenced within the University of Califor-
nia at Davis 100K Pathogen Genome Project using the PacBio RSII
sequencing platform (Pacific Biomarkers, Menlo Park, CA, USA).
High-molecular-weight gDNA was extracted from overnight cul-
tures grown on Trypticase soy agar, lysed with an enzyme cocktail,
purified with the QIAamp DNA minikit (Qiagen, Valencia, CA,
USA), and analyzed on a 2200 TapeStation system with the
Genomic DNA ScreenTape (Agilent Technologies, Santa Clara,
CA, USA) assay for integrity of high molecular weight gDNA (10).
After evaluation of gDNA size and quantity, 10
g was used for
fragmentation using the Covaris g-TUBE device (Covaris,
Woburn, MA, USA) following the manufacturer’s instructions
(11). The fragmented gDNA was used for library construction
with the PacBio SMRTbell 10kb Library preparation kit, which
was normalized to 1 to 5
g input. Libraries were sequenced
utilizing PacBio RSII and C2 chemistry with 100⫻coverage per
the manufacturer’s instructions. For each isolate, the genomic
sequence single-pass reads were de novo assembled using the
Hierarchical Genome Assembly Process (HGAP) version 1.4
software (Pacific Biosciences) and were then annotated using
the NCBI Prokaryotic Genomes Automatic Annotation Pipe-
line (http://www.ncbi.nlm.nih.gov/genome/annotation_prok)
(12). Through the annotation process, 4,771 and 4,937 genes for
the clinical and oyster isolates, respectively, as well as 4,579 and
4,731 coding regions were identified. The presence or absence of
the tdh and trh genes was confirmed in both isolates.
Nucleotide sequence accession numbers. The closed genome
sequences of the two V. parahaemolyticus isolates are available
in GenBank under the accession numbers CP006004 and
CP006005 for chromosomes I and II of FDA_R31, respectively,
and CP006008 and CP006007 for CDC_K4557. The versions de-
scribed in this paper are the first versions.
ACKNOWLEDGMENTS
This project was supported by an appointment to the Research Fellowship
Program for the Center for Food Safety and Applied Nutrition adminis-
tered by the Oak Ridge Associated Universities through a contract with
the FDA. The 100K Pathogen Genome Project was supported by the FDA
and Agilent Technologies to produce these sequences.
We thank Whitney Ng and Kao Thao for their effort in the isolate
logistics.
REFERENCES
1. Kueh CS, Chan KY. 1985. Bacteria in bivalve shellfish with special refer-
ence to the oyster. J Appl Bacteriol 59:41– 47. http://dx.doi.org/10.1111/
j.1365-2672.1985.tb01773.x.
crossmark
Genome AnnouncementsMarch/April 2015 Volume 3 Issue 2 e00216-15 genomea.asm.org 1
2. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy
SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United
States—major pathogens. Emerg Infect Dis 17:7–15. http://www.nc.cdc
.gov/eid/article/17/1/p1-1101_article.
3. Newton A, Kendall M, Vugia DJ, Henao OL, Mahon BE. 2012. Increas-
ing rates of vibriosis in the United States, 1996 –2010: review of surveil-
lance data from 2 systems. Clin Infect Dis 54(Suppl 5):S391–S395. http://
dx.doi.org/10.1093/cid/cis243.
4. Broberg CA, Calder TJ, Orth K. 2011. Vibrio parahaemolyticus cell biol-
ogy and pathogenicity determinants. Microbes Infect 13:992–1001. http://
dx.doi.org/10.1016/j.micinf.2011.06.013.
5. Depaola A, Jones JL, Woods J, Burkhardt W III, Calci KR, Krantz JA,
Bowers JC, Kasturi K, Byars RH, Jacobs E, Williams-Hill D, Nabe K.
2010. Bacterial and viral pathogens in live oysters: 2007 United States
market survey. Appl Environ Microbiol 76:2754 –2768. http://dx.doi.org/
10.1128/AEM.02590-09.
6. Depaola A, Kaysner CA, Bowers J, Cook DW. 2000. Environmental
investigations of Vibrio parahaemolyticus in oysters after outbreaks in
Washington, Texas, and New York (1997 and 1998). Appl Environ Micro-
biol 66:4649 – 4654.
7. Jones JL, Lüdeke CHM, Bowers JC, Garrett N, Fischer M, Parsons MB,
Bopp CA, DePaola A. 2012. Biochemical, serological, and virulence char-
acterization of clinical and oyster Vibrio parahaemolyticus isolates. J Clin
Microbiol 50:2343–2352. http://dx.doi.org/10.1128/JCM.00196-12.
8. Lynch T, Livingstone S, Buenaventura E, Lutter E, Fedwick J, Buret AG,
Graham D, DeVinney R. 2005. Vibrio parahaemolyticus disruption of
epithelial cell tight junctions occurs independently of toxin production.
Infect Immun 73:1275–1283. http://dx.doi.org/10.1128/IAI.73.3.1275
-1283.2005.
9. Park KS, Ono T, Rokuda M, Jang MH, Iida T, Honda T. 2004. Cyto-
toxicity and enterotoxicity of the thermostable direct hemolysin-deletion
mutants of Vibrio parahaemolyticus. Microbiol Immunol 48:313–318.
http://dx.doi.org/10.1111/j.1348-0421.2004.tb03512.x.
10. Jeannotte RE, Kong N, Ng W, Weimer BC. High-throughput analysis of
foodborne bacterial genomic DNA using Agilent 2200 TapeStation and Genomic
DNA ScreenTape system. Agilent Technologies, Santa Clara, CA. http://www
.chem.agilent.com/Library/applications/5991-4003EN.pdf. Accessed 11
February 2015.
11. Kong N, Thao K, Ng W, Kim KS, Korlach J, Hickey L, Kelly L, Lappin
S, Weimer BC. Automation of PacBio SMRTbell 10 kb template
preparation on an Agilent NGS Workstation. Agilent Technologies,
Santa Clara, CA. http://www.chem.agilent.com/Library/applications
/5991-4482EN.pdf. Accessed 11 February 2015.
12. Klimke W, Agarwala R, Badretdin A, Chetvernin S, Ciufo S, Fedorov B,
Kiryutin B, O’Neill K, Resch W, Resenchuk S, Schafer S, Tolstoy I,
Tatusova T. 2009. The National Center for Biotechnology Information’s
Protein Clusters Database. Nucleic Acids Res 37:D216 –D223. http://
dx.doi.org/10.1093/nar/gkn734.
Lüdeke et al.
Genome Announcements2genomea.asm.org March/April 2015 Volume 3 Issue 2 e00216-15
Content uploaded by Bart C Weimer
Author content
All content in this area was uploaded by Bart C Weimer on Oct 06, 2015
Content may be subject to copyright.